Welcome to the golden age of vaccine innovation

Severe asthma: when nature’s natural defences work against us

Complete the cycle – how we’re recycling inhalers

When we analysed our carbon footprint in 2010, two things became clear: we needed to take action to reduce it.

Why are we fighting malaria in the lab and on the ground?

Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.

How do consumer insights fuel our innovation?

By asking our consumers what matters to them, we can keep innovating and evolving our products.

Overcoming obstacles to end malaria

One of our lead physicians, Justin Green, tells us about the challenges of developing a new treatment for malaria.

How genomics is driving a new era of drug discovery

How are we redefining research in HIV?

Following the journey of a respiratory medicine

Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

COPD for John just means doing everything at a slower pace

Meet John - at 80 years old, he refuses to let COPD get in the way of living the life he wants to.

Making the Ellipta® inhaler a reality

The story behind the device now used by millions of people globally

Welcome to the golden age of vaccine innovation

Overcoming the challenges of COPD to fulfil a lifelong dream

Making sense of what consumers want

As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want.

The science of shopping

Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.

Breaking through the pain barrier: our latest research

From a passing headache to chronic back pain, we are working hard to better understand why we experience pain and develop more effective pain relief treatments.

I control my asthma, it doesn’t control me

Jamie from our Montrose site tells how he managed his asthma to conquer Mount Kenya

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

You'll outgrow some childhood habits, but vaccination is for life

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Does lupus really know no boundaries?

There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.

From TV to tackling lupus: why Alex moved from media to medicine

Alex Liakos on becoming a lupus medic, and listening to the patient

Giving a bit back – Christine’s experience of clinical research

For Christine even gentle exercise like jogging and walking her dogs around the park were a struggle. She just could not breathe properly.

Healthcare in your pocket

The race against malaria: handing the baton to the next generation

Win for Meningitis – harnessing the power of inspirational images to create a win for disease prevention

Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease.

Setting the record straight: Why we publish data both positive and negative

Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do.

Making the switch: how we’re improving access to proven medicines

Switching a medicine from prescription to over-the-counter places the power of managing everyday health conditions with the patient.

Supporting community health across the UK

Our GSK IMPACT Awards have been rewarding community health and wellbeing charities for the past 20 years.

30 years and counting: the fight against HIV

HIV research focus on finding a cure

What are Bioelectronics

We’re all familiar with the life-saving impact of pacemakers and defibrillators on the heart.

Live every breath

GSK have been innovating to fight respiratory disease for over 45 years.

Vaccines: the most successful health intervention… ever

Vaccines for preventable diseases

Joining forces to fight malaria

We’ve been fighting against malaria for the past 100 years and now we’ve joined forces with Comic Relief.

STEM inspiring real world scientists

The digitalisation lab: bringing the digital age to manufacturing

From academia to the pharmaceutical industry – one year on

Professor Ronald Dahl recently joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise.

COPD: Our relentless pursuit for better breathing

Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient.

Taking action to stop pneumonia

Pneumonia is a preventable and treatable disease.

Getting on target in autoimmune diseases

Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?

How smart is your inhaler?

Maternal immunisation: Helping protect mums and babies

Can social media help us hear patients?

Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines.

Tackling tomorrow’s health challenges today

Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow

Don’t forget the pharmacists

Dr. Sharmila Ramachandran and Dr. Aruni Mulgirigama talk about the essential role of pharmacists in asthma care

Rabies – Educate, Vaccinate, Eliminate.

28 September is World Rabies Day, when organisations across the globe, all with the common goal of eliminating human deaths from rabies by 2030, work together to raise awareness of this ‘neglected tropical disease’ under the theme ‘Educate, Vaccinate, Eliminate’.

Partnership for Prevention

Scientists or detectives? Seeking new clues in COPD

Collaboration: unlocking a new approach to clinical trials

The Salford Lung Study is a revolutionary clinical trial carried out in everyday practice that could significantly increase our understanding of the medicines doctors prescribe.

Helping to change the world

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

A new response to humanitarian crises

Humanitarian crises are becoming more frequent, more widespread and more complex. It’s clear that a new approach is needed.

A partnership that is all about the chemistry

See how our trainer trains sub Saharan Africa scientists in analytical chemistry.

Can an iPhone transform the way we monitor and improve patient health?

The app that could save lives

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Inhaler innovation: more than a simple piece of plastic

At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly...

From microscope to telescope and beyond – exploring with NASA's CASIS

What do space exploration and medical research have in common? And can they help each other?

Meet Baby Mckline: a special delivery from our Save the Children partnership

Mckline is a special little boy. Almost two years old, he lives in Kenya with his parents Catherine and Fredrick. They are already saving for his education and have ambitions for him to be an engineer one day.

Pro Mujer: supporting healthier lives in Latin America

From academia to industry: a new challenge

The design behind the device

Andy Dundon leads our R&D Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections. With an alarming rise in antibiotic resistance in recent years, this almost unthinkable scenario could be a reality.

Guardian article: The 30-year quest for a malaria vaccine

Dr Joe Cohen recalls his experiences of being part of the team to develop what could be the world’s first vaccine against malaria

Clinical Trials: Q&A with Murray Stewart

Giving mothers and babies a healthier start

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

The power of partnerships: transforming vaccine coverage in Mozambique

More than 35,000 children in the northern Mozambique province of Nampula are now registered with the mVacciNation pilot programme that was rolled out in 2015 by GSK and Vodafone, with funding from GAVI and USAID.

The value of vaccination

According to the World Health Organization, only clean drinking water rivals vaccination in its ability to save lives.

Beyond manufacturing in Chile and Madagascar

Why I #fightmalaria: Laura's story

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Living with lupus – a patient perspective

Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.

Does the relationship between the pharma industry and HCPs need to change?

We've changed how we interact with HCPs - how we incentivise our sales representatives, support medical education and stopping payments to HCPs for speaking on our behalf about our medicines.

Take a deep breath – your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity.

Helping to further science and research – Howard’s perspective

TB or not TB

Unlocking the secrets of the immune system to tackle disease

Paul-Peter Tak, Chief Immunology Officer and Senior Vice President R&D Pipeline, GSK, highlights the work we're doing to explore the immune system.

Bioelectronics at SXSW 2016

SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.

Delivering support for the most vulnerable communities

Healthcare charities tackle some of society’s most difficult and often overlooked challenges.

School leading the way to inspire young scientists

Dr Louise Morris wants every student at her school to have the education and opportunity to have a career in STEM.

Harnessing the electrical language of the body to treat disease

Telegraph article: Science hasn't answered all the questions on HIV

Igniting a revolution in scientific research and development

How can partnerships between science, business and charities help tackle some of the world's most challenging healthcare issues?

Guardian article: Making a change from the inside

Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.

Guardian article: A different way of doing business to support Kenyan mothers

Find out how we are helping to cut maternal and newborn mortality rates in Kenya.

See how GSK supports STEM in the real world

Explore how we invest in the scientists of the future.

Guardian article: Finding new ways to give mothers and newborns a healthier start

Disclosing information on payments to doctors has already had positive effects in Europe

Turning waste into a resource

We set a target to achieve ‘zero waste to landfill’ at all our sites by 2020. Already, over 60% of GSK sites and offices have achieved the target.

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda.

Comic Relief and GSK form a partnership to fight malaria

GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.

Intrapreneurship: keeping our fingers on the PULSE

We're encouraging our employees to explore new ideas beyond the remit of their role

Turbocharging the effect of vaccines

Helping to protect yourself against flu

Experimental medicine

Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies.

Outgrowing asthma

Why is it that some people, particularly children, grow out of their asthma? That’s a question our scientists are asking as part of our research to better understand the disease.

TEDMED 2015: An interview with curator, Christine McNab

We interview Christine McNab, curator of The Art of Saving a Life.

STEM in the real world

At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer.

TEDMED 2015: Art, inspired by vaccination

Living every day with COPD: José’s story

Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns

Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare.

Less is more with advanced technologies in manufacturing

Is ‘continuous manufacturing’ the best way to be greener?

Using biology to increase quality and reduce carbon footprint

We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients

Five years. 40,000 health workers. 11 million people.

What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?

Targeting the immune system through open innovation

To challenge. To change.

Health workers fighting it on the frontline

Almost everyone in Tanzania is at risk of malaria. The mosquito-borne disease is responsible for more than 10% of deaths among children under five in this East African country.

No 'silver bullet' to tackle this disease

The combination of increased funding, resources and education to fight malaria have contributed to a reduction in deaths from this mosquito-borne disease.

On the frontline of Ebola prevention

Read how Robbie worked on the ground to fight Ebola.

Ebola: our fast track response

GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.

Keeping ahead of the game

Fluorescent bacteria - nowhere to hide

Making our vaccines more accessible

We are determined to use our resources, knowledge and expertise to help improve access to immunisation.

Vaccines - coming in from the cold

‘Thermostability’ - it may sound very technical and complicated, but really it’s all about fridges.

Motivating a global coalition

GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?

Fighting Ebola highlights the need for more health workers

The race to richer data in clinical trials

Why our transaction with Novartis is different

What makes GSK’'s transaction with Novartis different?

Ebola vaccine R&D

Learn how we are advancing the development of our GSK/NIH Ebola vaccine candidate.

Forming public partnerships

The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.

Our humanitarian response to the Ebola outbreak

GSK's ongoing efforts to strengthen healthcare infrastructure in the most affected countries.

A healthier future for Africa

The critical workers boosting children’s health

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Africa’s fight against malaria: how mothers are helping on the ground

In a critical year in the fight against malaria, it will be community health workers and mothers themselves who play a vital role in helping to defeat the disease in Africa

Increasing access in India

Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population.

Helping women to give birth safely

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

Science of a different stripe

Bacteria: friends or foes?

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Data transparency

We have a long-standing commitment to data transparency.

Inside the Open Lab

How does the Tres Cantos Open Lab offer top international scientists and academics the opportunity to pursue their own projects as part of an integrated team?

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.

The 'baby bubble'

Eggs in manufacturing

Novamin - the accidental curist

One of the more compelling aspects of scientific research is the unexpected avenues down which it can lead.

'Rightsizing' our tablet packaging to reduce carbon emissions

How can you fit six tablets into the same space as four – and why would you want to?

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Algueta's smile: fighting lymphatic filariasis

Tijana Duric looks after the supply planning for albendazole in our neglected tropical diseases unit.

Life after polio: Fatiha's story